Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis

Clinical trial NCT02566057 · COMPLETED

Trial details

NCT number: NCT02566057
Sponsor: Northwell Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Schizophreniform Disorder Psychotic Disorders Bipolar Disorder

Start date: 2014-07-10
Primary completion: 2017-12-31
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.